S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Opera Stock: The Fast-Rising Star of AI-Driven Web Experiences
BREAKING: The truth about war with China (Ad)
What Should Investors Make of These 3 Dividend Cuts?
Symbotic AI Robots Disrupt Warehouse Industry, Stock Price Soars
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
CrowdStrike: Another Tech Stock to Buy on the Dip 
Broadcom Stock Pulls into the Buy Zone: Analysts Raise Targets
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
Salesforce: Time to Snap it Up as the Market Buys the Dip?
Zscaler: Analysts Raise the Bar for the AI Cloud Security Company
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Opera Stock: The Fast-Rising Star of AI-Driven Web Experiences
BREAKING: The truth about war with China (Ad)
What Should Investors Make of These 3 Dividend Cuts?
Symbotic AI Robots Disrupt Warehouse Industry, Stock Price Soars
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
CrowdStrike: Another Tech Stock to Buy on the Dip 
Broadcom Stock Pulls into the Buy Zone: Analysts Raise Targets
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
Salesforce: Time to Snap it Up as the Market Buys the Dip?
Zscaler: Analysts Raise the Bar for the AI Cloud Security Company
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Opera Stock: The Fast-Rising Star of AI-Driven Web Experiences
BREAKING: The truth about war with China (Ad)
What Should Investors Make of These 3 Dividend Cuts?
Symbotic AI Robots Disrupt Warehouse Industry, Stock Price Soars
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
CrowdStrike: Another Tech Stock to Buy on the Dip 
Broadcom Stock Pulls into the Buy Zone: Analysts Raise Targets
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
Salesforce: Time to Snap it Up as the Market Buys the Dip?
Zscaler: Analysts Raise the Bar for the AI Cloud Security Company
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Opera Stock: The Fast-Rising Star of AI-Driven Web Experiences
BREAKING: The truth about war with China (Ad)
What Should Investors Make of These 3 Dividend Cuts?
Symbotic AI Robots Disrupt Warehouse Industry, Stock Price Soars
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
CrowdStrike: Another Tech Stock to Buy on the Dip 
Broadcom Stock Pulls into the Buy Zone: Analysts Raise Targets
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
Salesforce: Time to Snap it Up as the Market Buys the Dip?
Zscaler: Analysts Raise the Bar for the AI Cloud Security Company
ASX:PME

Pro Medicus (PME) Stock Forecast, Price & News

Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
285,954 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
0.43%
Price Target
N/A

PME stock logo

About Pro Medicus (ASX:PME) Stock

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company provides its products under the Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease names. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.

Receive PME Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pro Medicus and its competitors with MarketBeat's FREE daily newsletter.

PME Stock News Headlines

We Called (ARWR) In Advance, Which Stocks Are Next?
Nearly 56% gains in 30 days! This bullish trend reversal was not only forecasted by A.I., but we called it 1 – 3 days in advance. If you have any money invested in the markets…even just your retirement, you’ll want to see this. Plus, it’s FREE - the training is only an hour & LIVE.
CSL shares dip despite new FDA approval
“Amazon Loophole” could hand you $28,544 in “royalty” payouts
Thanks to a little-known IRS loophole… Regular Americans can collect up to $28,544 (or more) in payouts from what Brad Thomas calls the “Amazon secret royalty program…” See how to collect the next payout before the strict cutoff deadline.
Visage 7 Named Best in KLAS 2023
Visage Announces Support of Amazon HealthLake Imaging
2 ASX stocks just received a “Perfect 10” Smart Score
Here’s 2 ASX stocks that just received a “Perfect 10” Smart Score
Pro Medicus Limited
See More Headlines


PME Company Calendar

Ex-Dividend for 3/23 Dividend
3/01/2023
Dividend Payable
3/23/2023
Today
6/03/2023

Industry, Sector and Symbol

Industry
Health Information Services
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
2,060
Year Founded
N/A

Profitability

Net Income
$50.95 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$106.67 million
Book Value
A$1.12 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
0.58

Key Executives

  • Dr. Sam Aaron Hupert M.B.B.S.
    M.D., Co-Founder, CEO, MD & Exec. Director
  • Mr. Anthony Barry Hall B.Sc.
    B.Sc.(Hons), M.Sc., Co-Founder, Technology Director & Exec. Director
  • Mr. Clayton James Hatch CPA
    B.Comm, CPA, CFO & Company Sec.
  • Dr. Malte Westerhoff
    GM of Europe & Global CTO
  • Mr. Brad Levin
    GM of North America & Global Head of Marketing
  • Mr. Sean Lambright
    Global Head of Sales - Visage Imaging Inc
  • Ms. Teresa Gschwind
    Global Head of Customer Service of Visage Imaging Inc.













PME Stock - Frequently Asked Questions

How often does Pro Medicus pay dividends? What is the dividend yield for Pro Medicus?

Pro Medicus announced a Interim dividend on Thursday, March 2nd. Stockholders of record on Thursday, March 23rd will be given a dividend of 0.13 per share on Thursday, March 23rd. This represents a dividend yield of 0.22%. The ex-dividend date of this dividend is Wednesday, March 1st. This is an increase from the stock's previous Interim dividend of A$0.07.
Read our dividend analysis for PME
.

Is Pro Medicus a good dividend stock?

Pro Medicus (ASX:PME) pays an annual dividend of A$0.26 per share and currently has a dividend yield of 0.43%. The dividend payout ratio is 53.06%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for PME.

What other stocks do shareholders of Pro Medicus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pro Medicus investors own include ImmuPharma (IMM), Blackmores (BKL), Bank of America (BAC), Boeing (BA), Accent Group (AX1), Axos Financial (AX), ARB (ARB), Appen (APX), Arista Networks (ANET) and Altium (ALU).

What is Pro Medicus' stock symbol?

Pro Medicus trades on the ASX under the ticker symbol "PME."

How much money does Pro Medicus make?

Pro Medicus (ASX:PME) has a market capitalization of $0.00 and generates $106.67 million in revenue each year. The company earns $50.95 million in net income (profit) each year or A$0.49 on an earnings per share basis.

How many employees does Pro Medicus have?

The company employs 2,060 workers across the globe.

How can I contact Pro Medicus?

The official website for the company is www.promed.com.au. The company can be reached via phone at 61 3 9429 8800.

This page (ASX:PME) was last updated on 6/3/2023 by MarketBeat.com Staff

My Account -